Citations

Mayo Clinic

Clear

545 citation(s) found for "Im, Melanie".

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy
Buzdar, Aman U. , Leitch, A. Marilyn , Unzeitig, Gary, Royce, Melanie , Suman, Vera J. , Meric‐Bernstam, Funda , Ellis, Matthew J. , Boughey, Judy C. , Hunt, Kelly K.

JAMA Oncology | September 7, 2018 | Volume: 5 | Issue: 1 | Pages: 45

10.1001/jamaoncol.2018.3691 | PMID 30193295 Get It

Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience
Kotwal, Anupam , Clark, Jennifer , Lyden, Melanie L. , McKenzie, Travis J. , Thompson, Geoffrey B. , Stan, Marius N. , Lyden, Melanie, McKenzie, Travis , Thompson, Geoffrey , Kudva, Yogish C , Stan, Marius N

Journal of the Endocrine Society | September 6, 2018 | Volume: 2 | Issue: 11 | Pages: 1226-1235

10.1210/js.2018-00259 | PMID 30370394 Get It

Prognostic value of tumor response in pediatric and adult patients with Ewing sarcoma.
Chihak, Melanie A., Keeney, Michael, Fritchie, Karen , Harmsen, William S. , Arndt, Carola A.S., Ruddy, Kathryn J. , Ahmed, Safia K. , Laack, Nadia N.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 10543-10543

10.1200/jco.2016.34.15_suppl.10543 Get It

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials
Bottomley, Andrew , Pe, Madeline , Sloan, Jeff A. , Basch, Ethan , Bonnetain, Franck, Calvert, Melanie , Campbell, Alicyn, Cleeland, Charles S. , Cocks, Kim , Collette, Laurence , Dueck, Amylou C. , Flechtner, Hans‐Henning , Gotay, Carolyn , Greimel, Eva , Griebsch, Ingolf , Grøenvold, Mogens , Hamel, Jean-François, King, Madeleine , Koller, Michael , Malone, Daniel C. , Martinelli, Francesca , Moinpour, Carol M. , Musoro, Jammbe , O’Connor, Daniel , Oliver, Kathy , Piault‐Louis, Elisabeth, Piccart, Martine , Pimentel, Francisco , Quinten, Chantal , Reijneveld, Jaap C. , Soltys, Katherine M, Sridhara, Rajeshwari , Taphoorn, Martin , Velikova, Galina , Coens, Corneel , Sloan, Jeff, Flechtner, Hans-Henning , Dueck, A. C. , Basch, Ethan , Devlin, Nancy J. , Kluetz, Paul Gustav , Mitchell, Sandra A , Schürmann, Christoph, Smith, Ashley Wilder

Clinical Trials | August 24, 2018 | Volume: 15 | Issue: 6 | Pages: 624-630

10.1177/1740774518795637 | PMID 30141714 Get It

Background There is currently a lack of consensus on how health-related quality of life and other patient-reported outcome measures in cancer randomized clinical trials are analyzed and interpreted. This makes it difficult to compare results across randomized controlled trials (RCTs) synthesize scientific research, and use that evidence to inform product labeling, clinical guidelines, and health policy. The Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data for Cancer Clinical Trials (SISAQOL) Consortium aims to develop guidelines and recommendations to standardize analyses of patient-reported outcome data in cancer RCTs. Methods and Results Members from the SISAQOL Consortium met in January 2017 to discuss relevant issues. Data from systematic reviews of the current state of published research in patient-reported outcomes in cancer RCTs indicated a lack of clear reporting of research hypothesis and analytic strategies, and inconsistency in definitions of terms, including “missing data,”“health-related quality of life,” and “patient-reported outcome.” Based on the meeting proceedings, the Consortium will focus on three key priorities in the coming year: developing a taxonomy of research objectives, identifying appropriate statistical methods to analyze patient-reported outcome data, and determining best practices to evaluate and deal with missing data. Conclusion The quality of the Consortium guidelines and recommendations are informed and enhanced by the broad Consortium membership which includes regulators, patients, clinicians, and academics.
Evaluation of the Bio-Rad BioPlex 2200 Toxoplasma gondii IgM Multiplex Flow Immunoassay
Theel, Elitza S. , Hilgart, Heather, Gronowski, Ann M., Yarbrough, Melanie L.

The Journal of Applied Laboratory Medicine | August 13, 2018 | Volume: 3 | Issue: 6 | Pages: 1022-1027

10.1373/jalm.2018.026906 | PMID 31639693 Get It

Abstract Background Toxoplasmosis is routinely diagnosed through detection of Toxoplasma gondii–specific antibodies. However, the imperfect specificity of T. gondii serologic assays is a well-recognized limitation. The new BioPlex 2200 (Bio-Rad Laboratories) T. gondii, rubella, and cytomegalovirus (ToRC) IgM multiplex flow immunoassay (MFI) received FDA clearance in May 2017. We evaluated the clinical performance of the new T. gondii IgM and existing IgG portion of this MFI. Methods Three hundred prospectively collected consecutive, residual sera, submitted for T. gondii serologic testing as part of routine clinical care, and an archived set of 52 residual sera previously positive for anti–T. gondii IgM and IgG with the predicate ADVIA Centaur Toxoplasma IgM and IgG assays (Siemens) were evaluated. Performance of the BioPlex 2200 T. gondii IgM and IgG MFIs was assessed by calculating positive (PPA) and negative percent agreement (NPA) compared to the Centaur tests. Results Among prospective specimens, the BioPlex 2200 T. gondii IgM and IgG MFIs demonstrated a PPA of 0% (0/7) and 82.3% (28/34) and NPA of 99.3% (288/290) and 95.8% (251/262), respectively, with the Centaur assays. Chart review of the 7 Centaur T. gondii IgM-positive samples revealed that these were likely falsely positive. Among archived samples, the BioPlex 2200 T. gondii IgM and IgG MFIs showed PPAs of 90.4% (47/52) and 100% (52/52), respectively. Conclusions The BioPlex 2200 T. gondii IgM and IgG MFIs demonstrated excellent concordance with the Centaur assays. The T. gondii IgM MFI may provide higher specificity in low-prevalence populations.
Morphometric Study of Pulmonary Arterial Changes in Pulmonary Langerhans Cell Histiocytosis
Bois, Melanie C. , May, Adam M. , Vassallo, Robert , Jenkins, Sarah M. , Yi, Eunhee S. , Roden, Anja C. , Vassallo, Robert , May, Adam M

Archives of Pathology & Laboratory Medicine | July 24, 2018 | Volume: 142 | Issue: 8 | Pages: 929-937

10.5858/arpa.2017-0463-oa | PMID 30040456 Get It

Context.— Pulmonary hypertension (PHT) is a complication of pulmonary Langerhans cell histiocytosis (PLCH); however, the pathogenesis remains largely unknown. Few studies have evaluated histopathologic changes in pulmonary arteries (PAs) of patients with PLCH; systematic quantification of arterial remodeling has yet to be undertaken. Objective.— To quantify the extent of arterial remodeling among patients with PLCH through morphometry and to correlate these results with pertinent clinical parameters. Design.— Patients with PLCH were identified from institutional files (1995–2015) along with age-, sex-, and smoking status–matched controls. Morphometric analysis of intimal and medial thickness of small to medium PAs was performed in patients with PLCH (within PLCH lesions [lesional] and away from PLCH lesions [nonlesional]) and controls. Paired measures were compared with Wilcoxon signed rank tests. Results.— Twenty-five patients with PLCH (14 men: median age, 46 years; interquartile range, 37–55 years) and 25 controls were included. The lesional arteries of patients with PLCH demonstrated thicker PA intima and media than controls (P < .001 and P < .001, respectively), as did PLCH nonlesional arteries compared to controls (P < .001 and P < .001, respectively). The PA intima and media were thicker within the PLCH lesions than nonlesional arteries (P = .02 and P = .002, respectively). Patients with PLCH-related PHT had a worse prognosis than those without PHT (P = .04; hazard ratio, 4.5 [1.1, 22.2]). Echocardiography parameters including right atrial size (P = .007), estimated right atrial pressure (P = .01), and right ventricular systolic pressure (P = .01) were inversely associated with survival. Conclusions.— Our findings suggest that factors other than direct vascular obstruction or inflammatory cell infiltration contribute, at least in part, to the vascular remodeling in PLCH.
Healed Fracture of Superior Horn of Thyroid Cartilage in Autoerotic Asphyxia: An Indication of Prior Activity? A Case Report Utilizing 3D Scanning and Printing of the Larynx
Eckhardt, Michael, Shah, Kabeer , Bois, Melanie C. , Maleszewski, Joseph J. , Moore, Kellyanna, Lin, Peter T. , Bois, Melanie, Maleszewski, Joseph, Lin, Peter , Eckhardt, Michael D.

Academic Forensic Pathology | June 27, 2018 | Volume: 8 | Issue: 1 | Pages: 170-179

10.23907/2018.012 | PMID 31240033 Get It

Evidence of prior autoerotic asphyxia is often difficult to establish due to the decedent's efforts to hide the activity from others. In this case report, we suggest that a healed fracture of the thyroid cartilage is indicative of prior autoerotic asphyxia activity. The decedent was a 45-year-old man who was found unclothed on the floor of his bedroom with a belt ligature around the neck. A second rope ligature was loosely wrapped around the decedent's wrists, scrotum, and penis. A definitive escape mechanism was not identified, but a nearby towel and barbell weight may have comprised a possible escape mechanism. There was no known history of depression or prior autoerotic activity. Autopsy was notable for the presence of a healed fracture of the right superior horn of the thyroid cartilage. Three-dimensional (3D) surface scanning and 3D printing was utilized to preserve the anatomical findings prior to histologic sampling. To our knowledge, this is the first reported use of 3D surface scanning and 3D printing for the purpose of documenting a forensic finding prior to alteration of the anatomical specimen for histologic sampling. Acute fractures of the superior horns of the thyroid cartilage are not infrequently seen in ligature hanging. Therefore, the presence of a healed fracture in the setting of autoerotic asphyxia likely indicates prior activity. Histologic sampling of the laryngeal cartilages to detect occult healed fractures in autoerotic asphyxia may be useful. Three-dimensional scanning and printing may alleviate concerns for specimen alteration due to histology sampling.
Evidence for telehealth group-based treatment: A systematic review
Gentry, Melanie T. , Clark, Matthew M. , Rummans, Teresa A. , Gentry, Melanie T , Lapid, Maria I.

Journal of Telemedicine and Telecare | May 23, 2018 | Volume: 25 | Issue: 6 | Pages: 327-342

10.1177/1357633x18775855 | PMID 29788807 Get It

Background Interest in the use of telehealth interventions to increase access to healthcare services is growing. Group-based interventions have the potential to increase patient access to highly needed services. The aim of this study was to systematically review the available literature on group-based video teleconference services. Methods The English-language literature was searched using Ovid MEDLINE, PubMed, PsycINFO and CINAHL for terms related to telehealth, group therapy and support groups. Abstracts were reviewed for relevance based on inclusion criteria. Multiple study types were reviewed, including open-label, qualitative and randomised controlled trial study designs. Data were compiled regarding participants, study intervention and outcomes. Specific areas of interest were the feasibility of and satisfaction with telehealth technology, as well as the effect of video teleconference delivery on group dynamics, including therapeutic alliance. Results Forty published studies met the inclusion criteria and were included in the review. Six were randomised controlled trials. Among the studies, there was a broad range of study designs, participants, group interventions and outcome measures. Video teleconference groups were found to be feasible and resulted in similar treatment outcomes to in-person groups. However, few studies were designed to demonstrate noninferiority of video teleconference groups compared with in-person groups. Studies that examined group process factors showed small decreases in therapeutic alliance in the video teleconference participants. Conclusions Video teleconference groups are feasible and produce outcomes similar to in-person treatment, with high participant satisfaction despite technical challenges. Additional research is needed to identify optimal methods of video teleconference group delivery to maximise clinical benefit and treatment outcomes.
A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment
Chandler, Melanie , Fields, Julie A. , Aakre, Jeremiah A. , Aakre, Jeremiah, Locke, Dona E.C. , Smith, Glenn E.

Journal of Alzheimer's Disease | May 22, 2018 | Volume: 63 | Issue: 4 | Pages: 1459-1468

10.3233/jad-171161 | PMID 29843239 Get It

The 14th International Workshops on Opportunistic Protists (IWOP 14)
Cushion, Melanie T. , Porollo, Aleksey , Saper, Vivian E , Sinai, Anthony P. , Weiss, Louis M. , Limper, Andrew H.

Journal of Eukaryotic Microbiology | May 3, 2018 | Volume: 65 | Issue: 6 | Pages: 934-939

10.1111/jeu.12631 | PMID 29722096 Get It

AbstractThe 14th International Workshops on Opportunistic Protists (IWOP‐14) was held August 10–12, 2017 in Cincinnati, OH, USA. The IWOP meetings focus on opportunistic protists (OIs); for example, free‐living amoebae, Pneumocystis spp., Cryptosporidium spp., Toxoplasma, the Microsporidia, and kinetoplastid flagellates. The highlights of Pneumocystis spp. research included the reports of primary homothallism for mating; a potential requirement for sexual replication in its life cycle; a new antigen on the surface of small asci; roles for CLRs, Dectin‐1, and Mincle in host responses; and identification of MSG families and mechanisms used for surface variation. Studies of Cryptosporidia spp. included comparative genomics, a new cryopreservation method; the role of mucin in attachment and invasion, and epidemiological surveys illustrating species diversity in animals. One of the five identified proteins in the polar tube of Microsporidia, PTP4, was shown to play a role in host infection. Zebrafish were used as a low cost vertebrate animal model for an evaluation of potential anti‐toxoplasma drugs. Folk medicine compounds with anti‐toxoplasma activity were presented, and reports on the chronic toxoplasma infection provided evidence for increased tractability for the study of this difficult life cycle stage. Escape from the parasitophorus vacuole and cell cycle regulation were the topics of the study in the acute phase.